Ledger.Open graph →
SEC Form D · filed October 25, 2017

Oyster Point Pharma, Inc

Offering
$43.1M
Sold
$28.6M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

William J. Link · San Francisco, CADirectorAli J. Behbahani · San Francisco, CADirectorD. M. Ackermann · San Francisco, CADirectorMark A. Murray · San Francisco, CAExec · DirectorJeffrey A. Nau · San Francisco, CAExec · DirectorD. M. Ackermann · San Francisco, CADirectorMark A. Murray · San Francisco, CAExec · DirectorWilliam J. Link · San Francisco, CADirectorJeffrey A. Nau · San Francisco, CAExec · DirectorAli J. Behbahani · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗